MRL/lpr lupus-prone mice were administered the B1R antagonist, SSR240612 for 12 weeks, and monitored for blood pressure, proteinuria, renal function, and serum autoantibodies. The gene discussed is BDKRB1; the disease is systemic lupus erythematosus.